Kevin Alan Schulman, MD, MBA


Professor of Medicine
Research Professor of Global Health
Director, Center for Clinical and Genetic Economics
Department / Division:
Medicine / General Internal Medicine
Address:
6042 N Pavilion Bldg
Durham, NC 27710
Office Telephone:
(919) 668-8101
Training:
  • MD, New York University, 1988
  • MBA, University of Pennsylvania, 1988
Research Interests:
Kevin A. Schulman, MD, MBA, is a professor of medicine and the Gregory Mario and Jeremy Mario Professor of Business Administration at Duke University. He is a visiting professor of business administration at Harvard Business School. He holds several leadership appointments at Duke. He is an associate director of the Duke Clinical Research Institute in the School of Medicine, the country's largest academic clinical research organization. In Duke's Fuqua School of Business, he served for more than a decade as the director of the Health Sector Management program, the Master of Management in Clinical Informatics degree program, and the Center for the Study of Health Management. His other university affiliations include the Trent Center for Bioethics, Humanities and History of Medicine; the Duke Translational Medicine Institute; and the Duke Global Health Institute.

Dr. Schulman is a distinguished researcher who has received more than $48 million in research grants. His research interests include health services research and policy, including access to care and the impact of reimbursement and regulatory policies on clinical practice; health economics and economic evaluation in clinical research; and medical decision making, especially in patients with life-threatening conditions. He teaches courses in biotechnology, health policy, and health IT strategy.

Dr. Schulman has published nearly 400 articles and book chapters; his peer-reviewed papers have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is the senior associate editor of Health Services Research and a member of the editorial/advisory boards of the American Journal of Medicine and the American Heart Journal.

A recipient of numerous awards, Dr. Schulman is a fellow of the American College of Physicians and an elected member of the American Society for Clinical Investigation. He is a voting member of the Medicare Evidence Development and Coverage Advisory Committee. He has served as session chair and panelist at dozens of medical and health care conferences. Dr. Schulman has also served on numerous grant review committees for the National Institutes of Health, the Robert Wood Johnson Foundation, and other bodies. He is a member of the advisory board for the Centre for Healthcare Policy and Management at the China Europe International Business School. In 2010-2011, he was a mentor for the Commonwealth Fund's Harkness Fellowships in Health Care Policy and Practice. He is the founding president of the Business School Alliance for Health Management, a consortium of the leading business schools offering health management programs.

Dr. Schulman received his MD from the New York University School of Medicine and his MBA, with a concentration in health care management, from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and is board-certified in internal medicine.
Representative Publications:
  • Baras, AI; Baras, AS; Schulman, KA. Drug development risk and the cost of capital. Nature Reviews Drug Discovery. 2012;11:347-348.  Abstract
  • Dinan, MA; Robinson, TJ; Zagar, TM; Scales Jr, CD; Curtis, LH; Reed, SD; Lee, WR; Schulman, KA. Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007. International Journal of Radiation: Oncology - Biology - Physics. 2012;82:e781-e786.  Abstract
  • Dinan, MA; Compton, KL; Dhillon, JK; Hammill, BG; Dewitt, EM; Weinfurt, KP; Schulman, KA. Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. Medical Care. 2011;49:415-419.  Abstract
  • Reed, SD; Eapen, ZJ; Schulman, KA. End point selection in acute decompensated heart failure clinical trials: economic end points. Heart Failure Clinics. 2011;7:529-537.  Abstract
  • Richman, BD; Schulman, KA. A cautious path forward on accountable care organizations. JAMA: Journal of the American Medical Association. 2011;305:602-603.  Abstract
  • Sampson, JH; Kaminski, TJ; Schulman, KA. Our failure to advance new treatments for glioma to market. Journal of Neurosurgery. 2011;115:245-247.  Abstract
  • Sullivan, R; Peppercorn, J; Sikora, K; Zalcberg, J; Meropol, NJ; Amir, E; Khayat, D; Boyle, P; Autier, P; Tannock, IF; Fojo, T; Siderov, J; Williamson, S; Camporesi, S; McVie, JG; Purushotham, AD; Naredi, P; Eggermont, A; Brennan, MF; Steinberg, ML; De Ridder, M; McCloskey, SA; Verellen, D; Roberts, T; Storme, G; Hicks, RJ; Ell, PJ; Hirsch, BR; Carbone, DP; Schulman, KA; Catchpole, P; Taylor, D; Geissler, J; Brinker, NG; Meltzer, D; Kerr, D; Aapro, M. Delivering affordable cancer care in high-income countries. Lancet Oncology. 2011;12:933-980.  Abstract
  • Ackerly, DC; Glickman, SW; Schulman, KA. Economic content in medical journal advertisements for medical devices and prescription drugs. PharmacoEconomics. 2010;28:429-438.  Abstract
  • Dinan, MA; Curtis, LH; Hammill, BG; Patz, EF; Abernethy, AP; Shea, AM; Schulman, KA. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA: Journal of the American Medical Association. 2010;303:1625-1631.  Abstract
  • Glickman, SW; Boulding, W; Manary, M; Staelin, R; Roe, MT; Wolosin, RJ; Ohman, EM; Peterson, ED; Schulman, KA. Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circulation: Cardiovascular Quality and Outcomes. 2010;3:188-195.  Abstract
  • Reed, SD; Whellan, DJ; Li, Y; Friedman, JY; Ellis, SJ; Piña, IL; Settles, SJ; Davidson-Ray, L; Johnson, JL; Cooper, LS; O'Connor, CM; Schulman, KA; HF-ACTION Investigators. Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure. Circulation: Cardiovascular Quality and Outcomes. 2010;3:374-381.  Abstract
  • Schulman, KA; Tunis, SR. A policy approach to the development of molecular diagnostic tests. Nature Biotechnology. 2010;28:1157-1159.  Abstract
  • Vaughn, BT; DeVrieze, SR; Reed, SD; Schulman, KA. Can we close the income and wealth gap between specialists and primary care physicians?. Health Affairs. 2010;29:933-940.  Abstract
  • Yancy, WS; Maciejewski, ML; Schulman, KA. Animal, vegetable, or ... clinical trial?. Annals of Internal Medicine. 2010;153:337-339.  Abstract
  • Ackerly, DC; Valverde, AM; Diener, LW; Dossary, KL; Schulman, KA. Fueling innovation in medical devices (and beyond): venture capital in health care. Health Affairs. 2009;28:w68-w75.  Abstract
  • DiMartino, LD; Hammill, BG; Curtis, LH; Gottdiener, JS; Manolio, TA; Powe, NR; Schulman, KA. External validity of the cardiovascular health study: a comparison with the Medicare population. Medical Care. 2009;47:916-923.  Abstract
  • Glickman, SW; Boulding, W; Roos, JM; Staelin, R; Peterson, ED; Schulman, KA. Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomes. Medical Care. 2009;47:1062-1068.  Abstract
  • Glickman, SW; McHutchison, JG; Peterson, ED; Cairns, CB; Harrington, RA; Califf, RM; Schulman, KA. Ethical and scientific implications of the globalization of clinical research. New England Journal of Medicine. 2009;360:816-823.  Abstract
  • Hall, MA; Schulman, KA. Ownership of medical information. JAMA: Journal of the American Medical Association. 2009;301:1282-1284.  Abstract
  • Reed, SD; Li, Y; Anstrom, KJ; Schulman, KA. Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. Journal of Clinical Oncology. 2009;27:2185-2191.  Abstract
  • Reed, SD; Schulman, KA. Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer. Value in Health. 2009;12:637-640.  Abstract
  • Schulman, KA; Vidal, AV; Ackerly, DC. Personalized medicine and disruptive innovation: implications for technology assessment. Genetics in Medicine. 2009;11:577-581.  Abstract
  • Chatterji, AK; Fabrizio, KR; Mitchell, W; Schulman, KA. Physician-industry cooperation in the medical device industry. Health Affairs. 2008;27:1532-1543.  Abstract
  • Curtis, LH; Hammill, BG; Bethel, MA; Anstrom, KJ; Liao, L; Gottdiener, JS; Schulman, KA. Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study. Current Medical Research and Opinion. 2008;24:41-50.  Abstract
  • Curtis, LH; Whellan, DJ; Hammill, BG; Hernandez, AF; Anstrom, KJ; Shea, AM; Schulman, KA. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Archives of Internal Medicine. 2008;168:418-424.  Abstract
  • Kyle, MK; Allsbrook, JS; Schulman, KA. Does reimportation reduce price differences for prescription drugs? Lessons from the European Union. Health Services Research. 2008;43:1308-1324.  Abstract
  • Reed, SD; Anstrom, KJ; Li, Y; Schulman, KA. Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia. PharmacoEconomics. 2008;26:435-446.  Abstract
  • Reed, SD; Anstrom, KJ; Seils, DM; Califf, RM; Schulman, KA. Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs. Health Affairs. 2008;27:w360-w370.  Abstract
  • Reed, SD; Shea, AM; Schulman, KA. Economic implications of potential changes to regulatory and reimbursement policies for medical devices. Journal of General Internal Medicine. 2008;23 Suppl 1:50-56.  Abstract
  • Richman, BD; Udayakumar, K; Mitchell, W; Schulman, KA. Lessons from India in organizational innovation: a tale of two heart hospitals. Health Affairs. 2008;27:1260-1270.  Abstract
  • Shea, AM; Curtis, LH; Hammill, BG; DiMartino, LD; Abernethy, AP; Schulman, KA. Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA: Journal of the American Medical Association. 2008;300:189-196.  Abstract
  • Shea, AM; Curtis, LH; Szczech, LA; Schulman, KA. Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States. BMC Nephrology. 2008;9:5.  Abstract
  • Shea, AM; Hammill, BG; Curtis, LH; Szczech, LA; Schulman, KA. Medical costs of abnormal serum sodium levels. Journal of the American Society of Nephrology. 2008;19:764-770.  Abstract
  • Takahashi, T; Reed, SD; Schulman, KA. Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease. Nephrology. 2008;13:419-427.  Abstract
  • Brown, TT; Scheffler, RM; Tom, SE; Schulman, KA. Does the market value racial and ethnic concordance in physician-patient relationships?. Health Services Research. 2007;42:706-726.  Abstract
  • Califf, RM; Harrington, RA; Madre, LK; Peterson, ED; Roth, D; Schulman, KA. Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics. Health Affairs. 2007;26:62-74.  Abstract
  • Curtis, LH; Al-Khatib, SM; Shea, AM; Hammill, BG; Hernandez, AF; Schulman, KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA: Journal of the American Medical Association. 2007;298:1517-1524.  Abstract
  • Curtis, LH; Hammill, BG; Bethel, MA; Anstrom, KJ; Gottdiener, JS; Schulman, KA. Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study. Diabetes Care. 2007;30:2553-2558.  Abstract
  • Eisenstein, EL; Anstrom, KJ; Kong, DF; Shaw, LK; Tuttle, RH; Mark, DB; Kramer, JM; Harrington, RA; Matchar, DB; Kandzari, DE; Peterson, ED; Schulman, KA; Califf, RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA: Journal of the American Medical Association. 2007;297:159-168.  Abstract
  • Friedman, JY; Curtis, LH; Hammill, BG; Dhillon, JK; Weaver, CH; Biswas, S; Abernethy, AP; Schulman, KA. The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?. Cancer. 2007;110:2304-2312.  Abstract
  • Glickman, SW; Baggett, KA; Krubert, CG; Peterson, ED; Schulman, KA. Promoting quality: the health-care organization from a management perspective. International Journal for Quality in Health Care. 2007;19:341-348.  Abstract
  • Glickman, SW; Ou, FS; DeLong, ER; Roe, MT; Lytle, BL; Mulgund, J; Rumsfeld, JS; Gibler, WB; Ohman, EM; Schulman, KA; Peterson, ED. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA: Journal of the American Medical Association. 2007;297:2373-2380.  Abstract
  • Kansagra, SM; Curtis, LH; Anstrom, KJ; Schulman, KA. Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001. American Journal of Cardiology. 2007;99:339-343.  Abstract
  • Li, JS; Eisenstein, EL; Grabowski, HG; Reid, ED; Mangum, B; Schulman, KA; Goldsmith, JV; Murphy, MD; Califf, RM; Benjamin, DK. Economic return of clinical trials performed under the pediatric exclusivity program. JAMA: Journal of the American Medical Association. 2007;297:480-488.  Abstract
  • Meropol, NJ; Schulman, KA. Cost of cancer care: issues and implications. Journal of Clinical Oncology. 2007;25:180-186.  Abstract
  • Shea, AM; Reed, SD; Curtis, LH; Alexander, MJ; Villani, JJ; Schulman, KA. Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery. 2007;61:1131-1137.  Abstract
  • Turer, AT; Mahaffey, KW; Compton, KL; Califf, RM; Schulman, KA. Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center. American Heart Journal. 2007;153:674-680.  Abstract
  • Whellan, DJ; Reed, SD; Liao, L; Gould, SD; O'connor, CM; Schulman, KA. Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives. American Journal of Cardiology. 2007;99:256-260.  Abstract
  • Williams, JE; Anstrom, KJ; Friedman, JY; Schulman, KA. Racial/ethnic variation in perceptions of medical information sources in Durham County, North Carolina. North Carolina Medical Journal. 2007;68:391-398.  Abstract
  • Curtis, LH; Stoddard, J; Radeva, JI; Hutchison, S; Dans, PE; Wright, A; Woosley, RL; Schulman, KA. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Services Research. 2006;41:837-855.  Abstract
  • Glickman, SW; Rasiel, EB; Hamilton, CD; Kubataev, A; Schulman, KA. Medicine. A portfolio model of drug development for tuberculosis. Science. 2006;311:1246-1247.  Abstract
  • Kauf, TL; Velazquez, EJ; Crosslin, DR; Weaver, WD; Diaz, R; Granger, CB; McMurray, JJ; Rouleau, JL; Aylward, PE; White, HD; Califf, RM; Schulman, KA. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. American Heart Journal. 2006;151:206-212.  Abstract
  • Reed, SD; Califf, RM; Schulman, KA. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation. Health Affairs. 2006;25:1309-1317.  Abstract
  • Reed, SD; Radeva, JI; Daniel, DB; Mody, SH; Forlenza, JB; McKenzie, RS; Schulman, KA. Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. PharmacoEconomics. 2006;24:479-494.  Abstract
  • Ridley, DB; Kramer, JM; Tilson, HH; Grabowski, HG; Schulman, KA. Spending on postapproval drug safety. Health Affairs. 2006;25:429-436.  Abstract
  • Schulman, KA. Medicare and cost-effectiveness analysis. New England Journal of Medicine. 2006;354:207-209.  Abstract
  • Torti, FM; Reed, SD; Schulman, KA. Analytic considerations in economic evaluations of multinational cardiovascular clinical trials. Value in Health. 2006;9:281-291.  Abstract
  • Chang, J; Kauf, TL; Mahajan, S; Jordan, JM; Kraus, VB; Vail, TP; Reed, SD; Omar, MA; Kahler, KH; Schulman, KA. Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis. Arthritis and Rheumatism. 2005;52:2366-2375.  Abstract
  • Curtis, LH; Masselink, LE; Østbye, T; Hutchison, S; Dans, PE; Wright, A; Krishnan, RR; Schulman, KA. Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Archives of Pediatrics and Adolescent Medicine. 2005;159:362-366.  Abstract
  • Friedman, JY; Anstrom, KJ; Weinfurt, KP; McIntosh, M; Bosworth, HB; Oddone, EZ; Bright, CM; Schulman, KA. Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samples. North Carolina Medical Journal. 2005;66:267-275.  Abstract
  • Ginsburg, GS; Konstance, RP; Allsbrook, JS; Schulman, KA. Implications of pharmacogenomics for drug development and clinical practice. Archives of Internal Medicine. 2005;165:2331-2336.  Abstract
  • Radeva, JI; Reed, SD; Kaló, Z; Kauf, TL; Cantu, E; Cretin, N; Schulman, KA. Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation. Clinical Transplantation. 2005;19:122-129.  Abstract
  • Rasiel, EB; Weinfurt, KP; Schulman, KA. Can prospect theory explain risk-seeking behavior by terminally ill patients?. Medical Decision Making. 2005;25:609-613.  Abstract
  • Reed, SD; Anstrom, KJ; Bakhai, A; Briggs, AH; Califf, RM; Cohen, DJ; Drummond, MF; Glick, HA; Gnanasakthy, A; Hlatky, MA; O'Brien, BJ; Torti, FM; Tsiatis, AA; Willan, AR; Mark, DB; Schulman, KA. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. American Heart Journal. 2005;149:434-443.  Abstract
  • Reed, SD; Radeva, JI; Daniel, DB; Fastenau, JM; Williams, D; Schulman, KA. Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia. Current Medical Research and Opinion. 2005;21:1527-1533.  Abstract
  • Reed, SD; Radeva, JI; Glendenning, GA; Coleman, RE; Schulman, KA. Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma. American Journal of Clinical Oncology: cancer clinical trials. 2005;28:8-16.  Abstract
  • Reed, SD; Radeva, JI; Weinfurt, KP; McMurray, JJ; Pfeffer, MA; Velazquez, EJ; Allsbrook, JS; Masselink, LE; Sellers, MA; Califf, RM; Schulman, KA; VALIANT Investigators. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). American Heart Journal. 2005;150:323-329.  Abstract
  • Weinfurt, KP; Li, Y; Castel, LD; Saad, F; Timbie, JW; Glendenning, GA; Schulman, KA. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Annals of Oncology. 2005;16:579-584.  Abstract
  • Whellan, DJ; Hasselblad, V; Peterson, E; O'Connor, CM; Schulman, KA. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. American Heart Journal. 2005;149:722-729.  Abstract
  • Anstrom, KJ; Reed, SD; Allen, AS; Glendenning, GA; Schulman, KA. Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. Cancer. 2004;101:2584-2592.  Abstract
  • Curtis, LH; Law, AW; Anstrom, KJ; Schulman, KA. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey. Medical Care. 2004;42:439-446.  Abstract
  • Curtis, LH; Østbye, T; Sendersky, V; Hutchison, S; Dans, PE; Wright, A; Woosley, RL; Schulman, KA. Inappropriate prescribing for elderly Americans in a large outpatient population. Archives of Internal Medicine. 2004;164:1621-1625.  Abstract
  • Friedman, JY; Reed, SD; Weinfurt, KP; Kahler, KH; Walter, EB; Schulman, KA. Parents' reported preference scores for childhood atopic dermatitis disease states. BMC Pediatrics. 2004;4:21.  Abstract
  • Gaskin, DJ; Weinfurt, KP; Castel, LD; DePuy, V; Li, Y; Balshem, A; Benson, A; Burnett, CB; Corbett, S; Marshall, J; Slater, E; Sulmasy, DP; Van Echo, D; Meropol, NJ; Schulman, KA. An exploration of relative health stock in advanced cancer patients. Medical Decision Making. 2004;24:614-624.  Abstract
  • Kansagra, SM; Curtis, LH; Schulman, KA. Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance. JAMA: Journal of the American Medical Association. 2004;292:1717-1723.  Abstract
  • Liao, L; Whellan, DJ; Tabuchi, K; Schulman, KA. Differences in care-seeking behavior for acute chest pain in the United States and Japan. American Heart Journal. 2004;147:630-635.  Abstract
  • Reed, SD; Anstrom, KJ; Ludmer, JA; Glendenning, GA; Schulman, KA. Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. Cancer. 2004;101:2574-2583.  Abstract
  • Reed, SD; Friedman, JY; Velazquez, EJ; Gnanasakthy, A; Califf, RM; Schulman, KA. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). American Heart Journal. 2004;148:122-128.  Abstract
  • Reed, SD; Radeva, JI; Glendenning, GA; Saad, F; Schulman, KA. Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. Journal of Urology. 2004;171:1537-1542.  Abstract
  • Ridley, DB; Schulman, KA. Differential pricing of pharmaceuticals in the internet age. Journal of Ambulatory Care Management. 2004;27:210-214.  Abstract
  • Seils, DM; Schulman, KA. Perceptions of racial and ethnic differences in access to healthcare. North Carolina Medical Journal. 2004;65:350-352.  Abstract
  • Sloan, FA; Trogdon, JG; Curtis, LH; Schulman, KA. The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction. Journal of the American Geriatrics Society. 2004;52:173-181.  Abstract
  • Torti, FM; Gwyther, LP; Reed, SD; Friedman, JY; Schulman, KA. A multinational review of recent trends and reports in dementia caregiver burden. Alzheimer Disease and Associated Disorders. 2004;18:99-109.  Abstract
  • Weinfurt, KP; Castel, LD; Li, Y; Timbie, JW; Glendenning, GA; Schulman, KA. Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. Medical Care. 2004;42:164-175.  Abstract
  • Castel, LD; Timbie, JW; Sendersky, V; Curtis, LH; Feather, KA; Schulman, KA. Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care. BMC Health Services Research. 2003;3:1.  Abstract
  • Curtis, LH; Østbye, T; Sendersky, V; Hutchison, S; Allen LaPointe, NM; Al-Khatib, SM; Usdin Yasuda, S; Dans, PE; Wright, A; Califf, RM; Woosley, RL; Schulman, KA. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. American Journal of Medicine. 2003;114:135-141.  Abstract
  • Law, AW; Reed, SD; Sundy, JS; Schulman, KA. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. Journal of Allergy and Clinical Immunology. 2003;111:296-300.  Abstract
  • Meropol, NJ; Weinfurt, KP; Burnett, CB; Balshem, A; Benson, AB; Castel, L; Corbett, S; Diefenbach, M; Gaskin, D; Li, Y; Manne, S; Marshall, J; Rowland, JH; Slater, E; Sulmasy, DP; Van Echo, D; Washington, S; Schulman, KA. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. Journal of Clinical Oncology. 2003;21:2589-2596.  Abstract
  • Polsky, D; Mandelblatt, JS; Weeks, JC; Venditti, L; Hwang, YT; Glick, HA; Hadley, J; Schulman, KA. Economic evaluation of breast cancer treatment: considering the value of patient choice. Journal of Clinical Oncology. 2003;21:1139-1146.  Abstract
  • Reed, SD; Friedman, JY; Gnanasakthy, A; Schulman, KA. Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial. International Journal of Technology Assessment in Health Care. 2003;19:396-406.  Abstract
  • Schulman, KA; Seils, DM. Outcomes research in oncology: improving patients' experiences with cancer treatment. Clinical Therapeutics: the international peer-reviewed journal of drug therapy. 2003;25:665-670.  Abstract
  • Schulman, KA; Stadtmauer, EA; Reed, SD; Glick, HA; Goldstein, LJ; Pines, JM; Jackman, JA; Suzuki, S; Styler, MJ; Crilley, PA; Klumpp, TR; Mangan, KF; Glick, JH. Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Bone Marrow Transplantation. 2003;31:205-210.  Abstract
  • Shah, BR; Reed, SD; Francis, J; Ridley, DB; Schulman, KA. The cost of inefficiency in US hospitals, 1985-1997. Journal of Health Care Finance. 2003;30:1-9.  Abstract
  • Sloan, FA; Trogdon, JG; Curtis, LH; Schulman, KA. Does the ownership of the admitting hospital make a difference? Outcomes and process of care of Medicare beneficiaries admitted with acute myocardial infarction. Medical Care. 2003;41:1193-1205.  Abstract
  • Onken, JE; Friedman, JY; Subramanian, S; Weinfurt, KP; Reed, SD; Malenbaum, JH; Schmidt, T; Schulman, KA. Treatment patterns and costs associated with sessile colorectal polyps. American Journal of Gastroenterology. 2002;97:2896-2901.  Abstract
  • Polsky, D; Keating, NL; Weeks, JC; Schulman, KA. Patient choice of breast cancer treatment: impact on health state preferences. Medical Care. 2002;40:1068-1079.  Abstract
  • Schulman, KA; Seils, DM; Timbie, JW; Sugarman, J; Dame, LA; Weinfurt, KP; Mark, DB; Califf, RM. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. New England Journal of Medicine. 2002;347:1335-1341.  Abstract
  • Weaver, CH; Buckner, CD; Curtis, LH; Bajwa, K; Weinfurt, KP; Wilson-Relyea, BJ; Schulman, KA. Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. Bone Marrow Transplantation. 2002;29:159-164.  Abstract
  • Weinfurt, KP; Trucco, SM; Willke, RJ; Schulman, KA. Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trials. An application of psychometric profile analysis. Journal of Clinical Epidemiology. 2002;55:608-618.  Abstract
  • Berger, AK; Breall, JA; Gersh, BJ; Johnson, AE; Oetgen, WJ; Marciniak, TA; Schulman, KA. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project). American Journal of Cardiology. 2001;87:272-277.  Abstract
  • DesHarnais Castel, L; Bajwa, K; Markle, JP; Timbie, JW; Zacker, C; Schulman, KA. A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease. Supportive Care in Cancer. 2001;9:545-551.  Abstract
  • Polsky, D; Weinfurt, KP; Kaplan, B; Kim, J; Fastenau, J; Schulman, KA. An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation. Nephrology Dialysis Transplantation. 2001;16:1028-1033.  Abstract
  • Schulman, KA; Yabroff, KR; Kong, J; Gold, KF; Rubenstein, LE; Epstein, AJ; Glick, H. A claims data approach to defining an episode of care. Pharmacoepidemiology and Drug Safety. 2001;10:417-427.  Abstract
  • Seils, DM; Friedman, JY; Schulman, KA. Sex differences in the referral process for invasive cardiac procedures. Journal- American Medical Womens Association. 2001;56:151-160.  Abstract
  • Einbinder, LC; Schulman, KA. The effect of race on the referral process for invasive cardiac procedures. Medical Care Research and Review. 2000;57 Suppl 1:162-180.  Abstract
  • Meehan, KR; Areman, EM; Ericson, SG; Matias, C; Seifeldin, R; Schulman, K. Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs. Stem Cells and Development. 2000;9:767-771.  Abstract
  • Meehan, KR; Matias, CO; Rathore, SS; Sandler, SG; Kallich, J; LaBrecque, J; Erder, H; Schulman, KA. Platelet transfusions: utilization and associated costs in a tertiary care hospital. American Journal of Hematology. 2000;64:251-256.  Abstract
  • Rathore, SS; Berger, AK; Weinfurt, KP; Feinleib, M; Oetgen, WJ; Gersh, BJ; Schulman, KA. Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation. 2000;102:642-648.  Abstract
  • Rathore, SS; Lenert, LA; Weinfurt, KP; Tinoco, A; Taleghani, CK; Harless, W; Schulman, KA. The effects of patient sex and race on medical students' ratings of quality of life. American Journal of Medicine. 2000;108:561-566.  Abstract
  • Sheifer, SE; Escarce, JJ; Schulman, KA. Race and sex differences in the management of coronary artery disease. American Heart Journal. 2000;139:848-857.  Abstract
  • Sheifer, SE; Rathore, SS; Gersh, BJ; Weinfurt, KP; Oetgen, WJ; Breall, JA; Schulman, KA. Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation. 2000;102:1651-1656.  Abstract
  • Weinfurt, KP; Willke, RJ; Glick, HA; Freimuth, WW; Schulman, KA. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Medical Care. 2000;38:404-410.  Abstract
  • Bentham, WD; Cai, L; Schulman, KA. Characteristics of hospitalizations of HIV-infected patients: an analysis of data from the 1994 healthcare cost and utilization project. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 1999;22:503-508.  Abstract
  • Boyko, WL; Glick, HA; Schulman, KA. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. ACE inhibitors in the management of congestive heart failure: comparative economic data. American Heart Journal. 1999;137:S115-S119.  Abstract
  • De Jonge, KE; Sulmasy, DP; Gold, KG; Epstein, A; Harper, MG; Eisenberg, JM; Schulman, KA. The timing of do-not-resuscitate orders and hospital costs. Journal of General Internal Medicine. 1999;14:190-192.  Abstract
  • Glick, HA; Polsky, D; Willke, RJ; Schulman, KA. A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Medical Decision Making. 1999;19:265-275.  Abstract
  • Mehta, SS; Suzuki, S; Glick, HA; Schulman, KA. Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care. 1999;22:1110-1115.  Abstract
  • Mehta, SS; Wilcox, CS; Schulman, KA. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP). American Journal of Hypertension. 1999;12:333-340.  Abstract
  • Schulman, KA; Abernethy, DR; Rathore, SS; Woosley, RL. Regulating manufacturer-affiliated communication in the information age. Clinical Pharmacology and Therapeutics. 1999;65:593-597.  Abstract
  • Schulman, KA; Berlin, JA; Harless, W; Kerner, JF; Sistrunk, S; Gersh, BJ; Dubé, R; Taleghani, CK; Burke, JE; Williams, S; Eisenberg, JM; Escarce, JJ. The effect of race and sex on physicians' recommendations for cardiac catheterization. New England Journal of Medicine. 1999;340:618-626.  Abstract
  • Schulman, KA; Birch, R; Zhen, B; Pania, N; Weaver, CH. Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support. Journal of Clinical Oncology. 1999;17:1227.  Abstract
  • Schulman, KA; Mehta, SS; Gersh, BJ; Schneider, EC; Wilcox, CS. Study of Hypertensive Prescribing Practices (SHyPP): A National Survey of Primary Care Physicians. Journal of Clinical Hypertension. 1999;1:106-114.  Abstract
  • Schulman, KA; Ohishi, A; Park, J; Glick, HA; Eisenberg, JM. Clinical economics in clinical trials: the measurement of cost and outcomes in the assessment of clinical services through clinical trials. Keio Journal of Medicine. 1999;48:1-11.  Abstract
  • Schulman, KA; Yabroff, KR; Kong, J; Gold, KF; Rubenstein, LE; Epstein, AJ; Glick, H. A claims data approach to defining an episode of care. Health Services Research. 1999;34:603-621.  Abstract
  • Sheifer, SE; Schulman, KA. Racial differences in the use of invasive cardiac procedures: A continuous quality improvement approach. American Heart Journal. 1999;138:396-399.  Abstract
  • Weinfurt, KP; Rathore, SS; Schulman, KA. ACI-TIPI clinical trial. Acute cardiac ischemia time-insensitive predictive instrument. Annals of Internal Medicine. 1999;131:476-477.  Abstract
  • Weinfurt, KP; Willke, R; Glick, HA; Schulman, KA. Towards a composite scoring solution for the Neurobehavioral Functioning Inventory. Quality of Life Research. 1999;8:17-24.  Abstract
  • Gaskin, DJ; Kong, J; Meropol, NJ; Yabroff, KR; Weaver, C; Schulman, KA. Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model. Medical Decision Making. 1998;18:84-94.  Abstract
  • Glick, H; Willke, R; Polsky, D; Llana, T; Alves, WM; Kassell, N; Schulman, K. Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage. Economic evaluation of a phase III clinical trial in Europe and Australia. International Journal of Technology Assessment in Health Care. 1998;14:145-160.  Abstract
  • Glick, HA; Polsky, D; Willke, RJ; Alves, WM; Kassell, N; Schulman, K. Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States. Stroke. 1998;29:351-358.  Abstract
  • Rathore, SS; Mehta, SS; Boyko, WL; Schulman, KA. Prescription medication use in older Americans: a national report card on prescribing. Family Medicine. 1998;30:733-739.  Abstract
  • Schulman, K; Burke, J; Drummond, M; Davies, L; Carlsson, P; Gruger, J; Harris, A; Lucioni, C; Gisbert, R; Llana, T; Tom, E; Bloom, B; Willke, R; Glick, H. Resource costing for multinational neurologic clinical trials: methods and results. Health Economics. 1998;7:629-638.  Abstract
  • Schulman, KA; Boyko, WL. Evaluating cancer costs in NCI trials. Cancer Treatment and Research. 1998;97:37-52.  Abstract
  • Schulman, KA; Dorsainvil, D; Yabroff, KR; DiCesare, J; Felser, J; Eisenberg, JM; Glick, HA. Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. IL-3 BMT Study Team. Bone Marrow Transplantation. 1998;21:607-614.  Abstract
  • Schulman, KA; Mark, DB; Califf, RM. Outcomes and costs within a disease management program for advanced congestive heart failure. American Heart Journal. 1998;135:S285-S292.  Abstract
  • Sulmasy, DP; Linas, BP; Gold, KF; Schulman, KA. Physician resource use and willingness to participate in assisted suicide. Archives of Internal Medicine. 1998;158:974-978.  Abstract
  • Willke, RJ; Glick, HA; Polsky, D; Schulman, K. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Economics. 1998;7:481-493.  Abstract
  • Mitchell, JM; Meehan, KR; Kong, J; Schulman, KA. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. Journal of Clinical Oncology. 1997;15:2644-2651.  Abstract
  • Polsky, D; Glick, HA; Willke, R; Schulman, K. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Economics. 1997;6:243-252.  Abstract
  • Roulidis, ZC; DeChant, HK; Schulman, KA. Resource utilization control processes as indicators of quality in managed care organizations: a proposal. American Journal of Medicine. 1997;103:146-151.  Abstract
  • Schulman, KA; Linas, BP. Pharmacoeconomics: state of the art in 1997. Annual Review of Public Health. 1997;18:529-548.  Abstract
  • Schulman, KA; Rubenstein, LE; Seils, DM; Harris, M; Hadley, J; Escarce, JJ. Quality assessment in contracting for tertiary care services by HMOs: a case study of three markets. The Joint Commission journal on quality improvement. 1997;23:117-127.  Abstract
  • Tom, E; Schulman, KA. Mathematical models in decision analysis. Infection Control and Hospital Epidemiology. 1997;18:65-73.  Abstract
  • DeChant, HK; Tohme, WG; Mun, SK; Hayes, WS; Schulman, KA. Health systems evaluation of telemedicine: a staged approach. Telemedicine and e-Health. 1996;2:303-312.  Abstract
  • Hirsch, JA; Langlotz, CP; Lee, J; Tanio, CP; Grossman, RI; Schulman, KA. Clinical assessment of MR of the brain in nonsurgical inpatients. American Journal of Neuroradiology. 1996;17:1245-1253.  Abstract
  • Knollmann, BC; Corson, AP; Twigg, HL; Schulman, KA. Assessment of joint review of radiologic studies by a primary care physician and a radiologist. Journal of General Internal Medicine. 1996;11:608-612.  Abstract
  • Schulman, KA. Economics of bone marrow transplantation. Journal of Clinical Oncology. 1996;14:1409-1410.  Abstract
  • Schulman, KA; Buxton, M; Glick, H; Sculpher, M; Guzman, G; Kong, J; Backhouse, M; Mauskopf, J; Bell, L; Eisenberg, JM. Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial. International Journal of Technology Assessment in Health Care. 1996;12:698-713.  Abstract
  • Schulman, KA; Glick, H; Buxton, M; Sculpher, M; Backhouse, M; Bell, L; Eisenberg, JM. The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan International Randomized Survival Trial. Contemporary Clinical Trials. 1996;17:304-315.  Abstract
  • Schulman, KA; Llana, T; Yabroff, KR. Economic assessment within the clinical development program. Medical Care. 1996;34:DS89-DS95.  Abstract
  • Schulman, KA; Rubenstein, LE; Abernethy, DR; Seils, DM; Sulmasy, DP. The effect of pharmaceutical benefits managers: is it being evaluated?. Annals of Internal Medicine. 1996;124:906-913.  Abstract
  • Yabroff, KR; Linas, BP; Schulman, K. Evaluation of quality of life for diverse patient populations. Breast Cancer Research and Treatment. 1996;40:87-104.  Abstract
  • Lee, JH; Glick, HA; Kinosian, B; Schulman, KA. An interactive computer system for formulary management using cost-effectiveness analysis. M.D. Computing. 1995;12:59-65.  Abstract
  • Schulman, K. Cost-effectiveness analyses. New England Journal of Medicine. 1995;332:124.  Abstract
  • Schulman, KA; Glick, HA. Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision. Journal of the National Cancer Institute Monographs. 1995;45-50.  Abstract
  • Schulman, KA; Glick, HA; Yabroff, KR; Eisenberg, JM. Introduction to clinical economics: assessment of cancer therapies. Journal of the National Cancer Institute Monographs. 1995;1-9.  Abstract
  • Schulman, KA; Rubenstein, LE; Chesley, FD; Eisenberg, JM. The roles of race and socioeconomic factors in health services research. Health Services Research. 1995;30:179-195.  Abstract
  • Schulman, KA; Rubenstein, LE; Glick, HA; Eisenberg, JM. Relationships between sponsors and investigators in pharmacoeconomic and clinical research. PharmacoEconomics. 1995;7:206-220.  Abstract
  • Schulman, KA; Yabroff, KR. Measuring the cost-effectiveness of cancer care. Oncology. 1995;9:523-533.  Abstract
  • Roulidis, ZC; Schulman, KA. Physician communication in managed care organizations: opinions of primary care physicians. Journal of Family Practice. 1994;39:446-451.  Abstract
  • Schulman, K; Sulmasy, DP; Roney, D. Ethics, economics, and the publication policies of major medical journals. JAMA: Journal of the American Medical Association. 1994;272:154-156.  Abstract
  • Schulman, KA; McDonald, RC; Lynn, LA; Frank, I; Christakis, NA; Schwartz, JS. Screening surgeons for HIV infection: assessment of a potential public health program. Infection Control and Hospital Epidemiology. 1994;15:147-155.  Abstract
  • Solomon, NA; Glick, HA; Russo, CJ; Lee, J; Schulman, KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-1725.  Abstract
  • Schulman, KA; Escarce, JJ; Eisenberg, JM; Hershey, JC; Young, MJ; McCarthy, DM; Williams, SV. Assessing physicians' estimates of the probability of coronary artery disease: the influence of patient characteristics. Medical Decision Making. 1992;12:109-114.  Abstract
  • Schulman, KA; Glick, HA; Rubin, H; Eisenberg, JM. Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent. JAMA: Journal of the American Medical Association. 1991;266:3466-3471.  Abstract
  • Schulman, KA; Lynn, LA; Glick, HA; Eisenberg, JM. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. Annals of Internal Medicine. 1991;114:798-802.  Abstract
  • Schulman, K. Screening for colorectal cancer. Annals of Internal Medicine. 1990;113:333-334.  Abstract
  • Schulman, KA; Kinosian, B; Jacobson, TA; Glick, H; Willian, MK; Koffer, H; Eisenberg, JM. Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management. JAMA: Journal of the American Medical Association. 1990;264:3025-3033.  Abstract
end fo content area